Skip to content
Wenlo
Sign in
← Markets

Waters Corporation

D Steven Conly (SVP, Waters Biosciences) reports WAT insider transactions

3WATFiled Nov 6, 2026, 6:59 PM ET· Period Oct 29, 2026

About this filing

Waters Corporation (WAT) filed Form 3 (initial insider holdings) with the SEC on Nov 6, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
D Steven Conly · SVP, Waters Biosciences

No transactions reported; holdings only.

Footnotes
  1. F1 Represents (i) 339 shares of the Issuer's common stock, (ii) 117 unvested restricted stock units ("RSUs") awarded under the Issuer's 2020 Equity Incentive Plan, and (iii) 5,574 unvested RSUs awarded under the Issuer's 2026 Equity-Based Incentive Plan in connection with the transactions set forth in that certain Agreement and Plan of Merger, dated as of July 13, 2025 (the "Merger Agreement"), by and among the Issuer, Becton, Dickinson and Company, Augusta SpinCo Corporation and Beta Merger Sub, Inc. The RSUs awarded under the 2020 Equity Incentive Plan will vest in four substantially equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
  2. F2 (Continued from footnote 1) The RSUs awarded under the 2026 Equity-Based Incentive Plan will vest as follows: 1,529 will vest on November 26, 2026; 279 will vest on March 3, 2027; 1,624 will vest on November 26, 2027; 278 will vest on March 3, 2028; and 1,864 will vest on November 26, 2028, subject to the Reporting Person's continued service with the Issuer on each such vesting date. All RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.
  3. F3 These stock appreciation rights were awarded under the Issuer's 2026 Equity-Based Incentive Plan in connection with the transactions set forth in the Merger Agreement.
  4. F4 These stock appreciation rights are fully vested and exercisable as of the date hereof.
  5. F5 These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2023, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
  6. F6 These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2024, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
  7. F7 These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2025, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
  8. F8 The shares of common stock underlying this stock option vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Remarks: Exhibit 24 - Power of Attorney

More WAT filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.